Patrone Lorenzo, Dharmarajah Braham, Korosoglou Grigorios, Theivacumar Selva, Antaredja Muliadi, Oberacker Ralph, Tilemann Lisa, Blessing Erwin
West London Vascular and Interventional Centre, London, UK.
West London Vascular and Interventional Centre, London, UK; Section of Vascular Surgery, Imperial College London, London, UK.
J Vasc Surg. 2022 Jan;75(1):177-185.e1. doi: 10.1016/j.jvs.2021.07.108. Epub 2021 Jul 22.
OBJECTIVE/BACKGROUND: Retrograde recanalizations gained increasing recognition in complex arterial occlusive disease. Re-entry devices are a well-described adjunct for antegrade recanalizations. We present our experience with retrograde, infrainguinal recanalizations using the Outback re-entry catheter in challenging chronic total occlusions.
We report data from a retrospective multicenter registry in complex retrograde recanalizations. Eligibility criteria included retrograde infrainguinal use of the Outback re-entry catheter where both conventional antegrade and retrograde recanalizations had been unsuccessful. Procedural outcomes included technical success (defined as successful wire passage and delivery of adjunctive therapy with <30% residual stenosis), safety (periprocedural complications, eg, bleeding, vessel injury, or occlusion of the artery at the re-entry site, and distal embolizations), and clinical outcome (amputation-free survival and freedom from clinically driven target lesion revascularization [cd-TLR]).
Forty-five consecutive patients underwent retrograde, infrainguinal recanalization attempts with the Outback re-entry catheter between February 2015 and August 2020. Thirty (67%) patients had a history of open vascular surgery in the index limb. In four patients, recanalizations were even more challenging due to previous surgical removal and/or ligation of the proximal segment of the superficial femoral artery. The retrograde access site of the Outback catheter was the femoropopliteal segment in 31 (69%) patients and crural vessels in 14 (31%) patients. The re-entry target sites were as follows: common femoral artery in 31 (69%) patients, superficial femoral artery in 9 (20%) patients, popliteal artery in 1 patient, and below-the-knee arteries in 2 patients. In four patients, the needle of the re-entry device was targeted to an inflated balloon, inserted via the antegrade route. The Outback re-entry catheter was placed via a 6-French sheath in 19 (42%) cases and sheathless in 26 (58%) cases. Technical success was achieved in 41 (91%) patients There were two instances of distal embolizations and three bleeding episodes. Amputation-free survival was 100% at 30 days, and after 12 months, freedom from cd-TLR was 95% at 30 days and 75% at 12 months of follow-up. Female sex was an independent predictor for cd-TLR at 12 months of follow-up.
Retrograde use of the Outback re-entry catheter in infrainguinal chronic total occlusions provides an effective and safe endovascular adjunct, when conventional antegrade and retrograde recanalization attempts have failed.
目的/背景:逆行再通术在复杂动脉闭塞性疾病中越来越受到认可。再入路装置是顺行再通术中一种广为人知的辅助手段。我们介绍了使用Outback再入路导管进行逆行性股腘以下再通术治疗具有挑战性的慢性完全闭塞病变的经验。
我们报告了一项关于复杂逆行再通术的回顾性多中心注册研究的数据。纳入标准包括在常规顺行和逆行再通术均失败的情况下,逆行性股腘以下使用Outback再入路导管。手术结果包括技术成功(定义为导丝成功通过并进行辅助治疗,残余狭窄<30%)、安全性(围手术期并发症,如出血、血管损伤、再入路部位动脉闭塞以及远端栓塞)和临床结果(无截肢生存以及免于临床驱动的靶病变血管重建术[cd-TLR])。
2015年2月至2020年8月期间,连续45例患者尝试使用Outback再入路导管进行逆行性股腘以下再通术。30例(67%)患者在患侧肢体有开放性血管手术史。在4例患者中,由于先前手术切除和/或结扎股浅动脉近端段,再通术更具挑战性。Outback导管的逆行入路部位在31例(69%)患者中为股腘段,在14例(31%)患者中为小腿血管。再入路目标部位如下:31例(69%)患者为股总动脉,9例(20%)患者为股浅动脉,1例患者为腘动脉,2例患者为膝下动脉。在4例患者中,再入路装置的穿刺针指向通过顺行途径插入的充盈球囊。19例(42%)病例通过6F鞘管置入Outback再入路导管,26例(58%)病例无鞘置入。41例(91%)患者实现了技术成功。有2例发生远端栓塞,3例出现出血事件。30天时无截肢生存率为100%,随访12个月时,30天时免于cd-TLR的比例为95%,12个月时为75%。女性是随访12个月时cd-TLR的独立预测因素。
当常规顺行和逆行再通术尝试失败时,在股腘以下慢性完全闭塞病变中逆行使用Outback再入路导管可提供一种有效且安全的血管内辅助手段。